Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
Main Authors: | Fessenden, Tim B, Stopfer, Lauren E, Chatterjee, Fiona, Zulueta, Julian, Mesfin, Josh, Cordero Dumit, Therese, Reijers, Irene, Hoefsmit, Esmee P, Blank, Christian, White, Forest, Spranger, Stefani |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
BMJ
2023
|
Online Access: | https://hdl.handle.net/1721.1/146988 |
Similar Items
-
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
by: Stefani Spranger, et al.
Published: (2022-07-01) -
538 Harnessing cross-dressing dendritic cells to strengthen anti-tumor immunity
by: Stefani Spranger, et al.
Published: (2020-11-01) -
947 The activation states of tumor-resident type 2 dendritic cells impact the strength of ovarian cancer immune responses
by: Stefani Spranger, et al.
Published: (2023-11-01) -
A team effort: natural killer cells on the first leg of the tumor immunity relay race
by: Timothy B. Fessenden, et al.
Published: (2018-07-01) -
A team effort: natural killer cells on the first leg of the tumor immunity relay race
by: Fessenden, Timothy B, et al.
Published: (2018)